Terms: = Breast cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Diagnosis
14 results:
1. A Deep Survival EWAS approach estimating risk profile based on pre-diagnostic DNA methylation: An application to breast cancer time to diagnosis.
Massi MC; Dominoni L; Ieva F; Fiorito G
PLoS Comput Biol; 2022 Sep; 18(9):e1009959. PubMed ID: 36155971
[TBL] [Abstract] [Full Text] [Related]
2. Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments.
Haidari RE; Anota A; Dabakuyo-Yonli TS; Guillemin F; Conroy T; Velten M; Jolly D; Causeret S; Cuisenier J; Graesslin O; Abbas LA; Nerich V
Qual Life Res; 2022 Oct; 31(10):3077-3085. PubMed ID: 35590124
[TBL] [Abstract] [Full Text] [Related]
3. Significant association between ercc2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract] [Full Text] [Related]
4. A situational analysis of breast cancer early detection services in Trinidad and Tobago.
Badal K; Rampersad F; Warner WA; Toriola AT; Mohammed H; Scheffel HA; Ali R; Moosoodeen M; Konduru S; Russel A; Haraksingh R
Cancer Causes Control; 2018 Jan; 29(1):33-42. PubMed ID: 28801763
[TBL] [Abstract] [Full Text] [Related]
5. Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of breast cancer.
Verde Z; Santiago C; Chicharro LM; Reinoso-Barbero L; Tejerina A; Bandrés F; Gómez-Gallego F
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754415
[TBL] [Abstract] [Full Text] [Related]
6. Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study.
Moriceau G; Bourmaud A; Tinquaut F; Oriol M; Jacquin JP; Fournel P; Magné N; Chauvin F
Oncotarget; 2016 Jan; 7(1):1055-65. PubMed ID: 26540571
[TBL] [Abstract] [Full Text] [Related]
7. Impact of response shift on time to deterioration in quality of life scores in breast cancer patients.
Hamidou Z; Dabakuyo-Yonli TS; Guillemin F; Conroy T; Velten M; Jolly D; Causeret S; Graesslin O; Gauthier M; Mercier M; Bonnetain F
PLoS One; 2014; 9(5):e96848. PubMed ID: 24828426
[TBL] [Abstract] [Full Text] [Related]
8. Role of XRCC3, XRCC1 and xpd single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.
Castro E; Olmos D; Garcia A; Cruz JJ; González-Sarmiento R
Clin Transl Oncol; 2014 Feb; 16(2):158-65. PubMed ID: 23740134
[TBL] [Abstract] [Full Text] [Related]
9. Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.
Smith TR; Liu-Mares W; Van Emburgh BO; Levine EA; Allen GO; Hill JW; Reis IM; Kresty LA; Pegram MD; Miller MS; Hu JJ
Carcinogenesis; 2011 Sep; 32(9):1354-60. PubMed ID: 21700777
[TBL] [Abstract] [Full Text] [Related]
10. Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology.
Lubiński J; Korzeń M; Górski B; Cybulski C; Debniak T; Jakubowska A; Jaworska K; Wokołorczyk D; Medrek K; Matyjasik J; Huzarski T; Byrski T; Gronwald J; Masojć B; Lener M; Szymańska A; Szymańska-Pasternak J; Serrano-Fernàndez P; Piegat A; Uciński R; Domagała P; Domagała W; Chosia M; Kładny J; Górecka B; Narod S; Scott R
Breast Cancer Res Treat; 2009 Mar; 114(1):121-6. PubMed ID: 18415014
[TBL] [Abstract] [Full Text] [Related]
11. Polymorphisms in XPC and ercc2 genes, smoking and breast cancer risk.
Shore RE; Zeleniuch-Jacquotte A; Currie D; Mohrenweiser H; Afanasyeva Y; Koenig KL; Arslan AA; Toniolo P; Wirgin I
Int J Cancer; 2008 May; 122(9):2101-5. PubMed ID: 18196582
[TBL] [Abstract] [Full Text] [Related]
12. Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer.
Hardenbergh PH; Recht A; Gollamudi S; Come SE; Hayes DF; Shulman LN; O'Neill A; Gelman RS; Silver B; Harris JR
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):69-72. PubMed ID: 10477008
[TBL] [Abstract] [Full Text] [Related]
13. [Treatment of febrile neutropenia in patients with solid tumors].
Novotný J; Petruzelka L; Jedlicková A; Mikolásová B
Cas Lek Cesk; 1998 Nov; 137(22):694-9. PubMed ID: 9929937
[TBL] [Abstract] [Full Text] [Related]
14. Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire cancer Registry.
Seddon DJ; Williams EM
Br J Cancer; 1997; 76(5):667-74. PubMed ID: 9303369
[TBL] [Abstract] [Full Text] [Related]
